4//SEC Filing
AGIOS PHARMACEUTICALS INC 4
Accession 0001209191-15-085756
$AGIOCIK 0001439222operating
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:02 PM ET
Size
5.2 KB
Accession
0001209191-15-085756
Insider Transaction Report
Form 4
Higgons John Duncan
Chief Operating Officer10% Owner
Transactions
- Sale
Common stock
2015-12-15$50.09/sh−20,000$1,001,800→ 61,835 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.00 to $50.36. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
AGIOS PHARMACEUTICALS INC
CIK 0001439222
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001439222
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:02 PM ET
- Size
- 5.2 KB